|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 23595 |
FusionGeneSummary for NCK2_NUP93 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: NCK2_NUP93 | Fusion gene ID: 23595 | Hgene | Tgene | Gene symbol | NCK2 | NUP93 | Gene ID | 8440 | 9688 |
| Gene name | NCK adaptor protein 2 | nucleoporin 93 | |
| Synonyms | GRB4|NCKbeta | NIC96 | |
| Cytomap | 2q12.2 | 16q13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | cytoplasmic protein NCK2SH2/SH3 adaptor protein NCK-betagrowth factor receptor-bound protein 4noncatalytic region of tyrosine kinase, beta | nuclear pore complex protein Nup9393 kDa nucleoporinnucleoporin 93kDanucleoporin Nup93 | |
| Modification date | 20180522 | 20180523 | |
| UniProtAcc | O43639 | Q8N1F7 | |
| Ensembl transtripts involved in fusion gene | ENST00000233154, ENST00000451463, ENST00000522586, ENST00000393349, | ENST00000308159, ENST00000569842, ENST00000564887, ENST00000569595, ENST00000542526, | |
| Fusion gene scores | * DoF score | 6 X 4 X 5=120 | 8 X 8 X 5=320 |
| # samples | 6 | 7 | |
| ** MAII score | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/320*10)=-2.1926450779424 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: NCK2 [Title/Abstract] AND NUP93 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | NCK2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 16835242 |
| Hgene | NCK2 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 10026169 |
| Hgene | NCK2 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation | 16835242 |
| Tgene | NUP93 | GO:0006998 | nuclear envelope organization | 26878725 |
| Tgene | NUP93 | GO:0051292 | nuclear pore complex assembly | 26878725 |
| Tgene | NUP93 | GO:0060391 | positive regulation of SMAD protein signal transduction | 26878725 |
| Tgene | NUP93 | GO:0060395 | SMAD protein signal transduction | 26878725 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | MESO | TCGA-ZN-A9VP-01A | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000233154 | ENST00000308159 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-5UTR | ENST00000233154 | ENST00000569842 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000233154 | ENST00000564887 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000233154 | ENST00000569595 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000233154 | ENST00000542526 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-5UTR | ENST00000451463 | ENST00000308159 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-5UTR | ENST00000451463 | ENST00000569842 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000451463 | ENST00000564887 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000451463 | ENST00000569595 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000451463 | ENST00000542526 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-5UTR | ENST00000522586 | ENST00000308159 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-5UTR | ENST00000522586 | ENST00000569842 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000522586 | ENST00000564887 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000522586 | ENST00000569595 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000522586 | ENST00000542526 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-5UTR | ENST00000393349 | ENST00000308159 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-5UTR | ENST00000393349 | ENST00000569842 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000393349 | ENST00000564887 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000393349 | ENST00000569595 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
| 5CDS-intron | ENST00000393349 | ENST00000542526 | NCK2 | chr2 | 106471745 | + | NUP93 | chr16 | 56782146 | + |
Top |
FusionProtFeatures for NCK2_NUP93 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| NCK2 | NUP93 |
| Adapter protein which associates with tyrosine-phosphorylated growth factor receptors or their cellularsubstrates. Maintains low levels of EIF2S1 phosphorylation bypromoting its dephosphorylation by PP1. Plays a role in ELK1-dependent transcriptional activation in response to activated Rassignaling. {ECO:0000269|PubMed:10026169,ECO:0000269|PubMed:16835242}. | Plays a role in the nuclear pore complex (NPC) assemblyand/or maintenance (PubMed:9348540). May anchor nucleoporins, butnot NUP153 and TPR, to the NPC. During renal development,regulates podocyte migration and proliferation through SMAD4signaling (PubMed:26878725). {ECO:0000269|PubMed:15229283,ECO:0000269|PubMed:15703211, ECO:0000269|PubMed:26878725,ECO:0000269|PubMed:9348540}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NCK2_NUP93 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NCK2_NUP93 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| NCK2 | ABI2, TRIP6, KIAA1217, NCKIPSD, SF3B4, CBLB, WBP11, CPSF6, FXR2, CPSF7, HNRNPK, EEF1G, EGFR, PDGFRB, DOK1, DOCK1, WIPF2, CD3E, PTK2, PAK1, PKN2, SOS1, NTRK2, LIMS1, ILK, IRS1, MASP1, KHDRBS1, BLNK, FASLG, ATN1, EFNB1, ABI1, AXIN1, DNM1, ERBB2, ERBB3, SRPK2, SRPK1, SYNPO, WAS, CBL, PSMD10, CHN1, DVL1, NR5A1, HOXC4, LCP2, MAGEA6, MEOX2, REL, TRIM27, TCF4, TNR, RASSF7, NCK2, SORBS2, EIF3H, WASL, ARHGAP32, SPRY2, DRAP1, ZBTB7B, ABI3, FAM53C, BCL11A, VARS2, HOMEZ, RBM26, FCRL2, VPS37B, CCDC33, EFHC2, LZTS2, LNX1, TRIM41, PRR20A, LRRIQ3, UBC, DYX1C1, NCK1, SH3PXD2B, ARAP1, NCKAP1, ABL2, GIT2, GIT1, RAPH1, BAIAP2, ASAP2, ASAP1, CYFIP2, CYFIP1, PRRC2A, TNK2, MAP4K4, MINK1, TNIK, PAK2, NHSL1, CASKIN2, PEAK1, ARHGEF7, ARHGEF6, WASF1, WASF2, WASF3, TTC28, PIK3AP1, SHB, WIPF1, KIAA1522, NHSL2, MLLT4, WIPF3, LZTR1, SEMA6A, FAM83H, BRK1, FAM217B, FYB, SORBS1, CEP170, CEP44, CEP19, TRIM15, FGFR1, CDH1, PTPN12, LRFN4, DOK2, CPNE5, YLPM1, SMARCB1 | NUP93 | PHLDA3, GIPC1, CASP4, PNKP, NEK6, TSC22D1, PHB2, BRF2, MYC, TPR, PAN2, RAE1, AIRE, CLN3, RYK, HDAC5, PIDD1, ELAVL1, SIRT7, CUL3, NXF1, TLN2, ECT2, VCAM1, ITGA4, AICDA, SOX2, HDAC9, HDAC11, ADRB2, BAG3, NUP62, EGFR, FBXO6, CUL7, OBSL1, CCDC8, SUZ12, EED, RNF2, KCMF1, FGG, MTPN, NUP205, NUP188, UBA1, UBA6, UCHL3, NTRK1, SCARNA22, KRAS, IFI16, NUP35, KPNB1, UBE2I, XRCC3, NUPL1, NUP153, NUP107, SEH1L, CDC5L, SENP3, RNF126, OTUB1, BMI1, CTDSPL2, DLST, PDHA1, SOD1, BRCA1, TES |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NCK2_NUP93 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NCK2_NUP93 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | NCK2 | C0001925 | Albuminuria | 1 | CTD_human |
| Hgene | NCK2 | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
| Hgene | NCK2 | C0033687 | Proteinuria | 1 | CTD_human |
| Tgene | NUP93 | C1868672 | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1 | CTD_human |
| Tgene | NUP93 | C4225166 | NEPHROTIC SYNDROME, TYPE 12 | 1 | UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|